Trial Profile
Safety and efficacy of everolimus De Novo renal transplanted patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate sodium; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2016 New trial record
- 01 Mar 2016 Results published in the Transplantation Proceedings